Compound: benazepril
SMILES: O=C1N(c2c(cccc2)CC[C@@H]1N[C@H](C(=O)OCC)CCc3ccccc3)CC(=O)O
InChIKey: XPCFTKFZXHTYIP-PMACEKPBSA-N
Synonyms: benazepril, 86541-75-5, Benazeprilum, Benazeprilum [Latin], Benazepril Sandoz, Briem, Forteekor, CGS-14824A, Cibacen ws, UDM7Q7QWP8, 2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid, C09AA07, CHEBI:3011, 1H-1-Benzazepine-1-acetic acid, 3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, (S-(R*,R*))-, DTXSID5022645, Benazeprilum (Latin), 2-[(3S)-3-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid, benazapril, benzazepril, 2-((3S)-3-(((2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)acetic acid, 2-((3S)-3-(((2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl)acetic acid, RefChem:54434, DTXCID602645, Benazepril (INN), Benazepril Free base, MFCD00864466, CHEMBL838, 109010-10-8, BENAZEPRIL [INN], Benazepril, (+/-)-, Benazepril [INN:BAN], [(3S)-3-{[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid, [(3S)-3-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid, 1H-1-Benzazepine-1-acetic acid, 3-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-, (3S)-, 2-((S)-3-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetic acid, Benazepril (hydrochloride), CGS-14824-A, PX47FSF9B3, Benazepril impurity A, UNII-UDM7Q7QWP8, Forteekor [veterinary] (TN), Benazepril (Standard), Spectrum_001922, BENAZEPRIL [MI], Spectrum2_000482, Spectrum3_001674, Spectrum4_000286, Spectrum5_001546, BENAZEPRIL [VANDF], BENAZEPRIL [WHO-DD], SCHEMBL16396, BSPBio_003487, KBioGR_000812, KBioSS_002464, MLS006011854, BIDD:GT0800, SPBio_000343, GTPL6374, orb1705329, SCHEMBL29382644, HSDB 7081, HY-B0093R, KBio2_002457, KBio2_005025, KBio2_007593, KBio3_002707, (3S)-3-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic Acid, HY-B0093, BBL034011, BDBM50021153, EBC-27047, s5938, STK627447, AKOS005560204, CS-1795, DB00542, BENAZEPRIL [EMA EPAR VETERINARY], NCGC00165740-01, NCGC00165740-02, NCGC00165740-03, NCGC00165740-04, [(3S)-3-({(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}amino)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid, 2-[(3S)-3-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid, 86499-21-0, FB171048, SMR000857173, SY028603, SBI-0206744.P001, NS00010378, C06843, D07499, AB00698518-07, AB00698518_08, AB00698518_09, EN300-6481298, Q592802, BRD-K49807096-003-02-3, BRD-K49807096-003-14-8, BRD-K49807096-003-15-5, BRD-K49807096-003-16-3, Tert butyl-3-(3S)amino-2,3,4,5-tetrahydro-1h(1)benzazepin-2-one-1-acetate, 1H-1-Benzazepine-1-acetic acid, 3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-, (3R)-rel-, 1H-1-Benzazepine-1-acetic acid, 3-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-, (R*,R*)-, 1H-1-Benzazepine-1-acetic acid, 3-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-, (R*,R*)-(+/-)-, 2-[(S)-3-[[(S)-1-Ethoxy-1-oxo-4-phenyl-2-butanyl]amino]-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl]acetic Acid, rel-(3R)-3-[[(1R)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid
Theoretical properties:
molecular_formula: C24H28N2O5
molecular_weight: 424.5 g/mol
exact_mass: 424.19982200 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 2
hydrogen_bond_acceptor_count: 6
rotatable_bond_count: 10
heavy_atom_count: 31
topological_polar_surface_area: 95.9 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
solubility: 19mg/mL
Descriptions:
{"pubchem": "Benazepril is a benzazepine that is benazeprilat in which the carboxy group of the 2-amino-4-phenylbutanoic acid moiety has been converted to the corresponding ethyl ester. It is used (generally as its hydrochloride salt) as a prodrug for the angiotensin-converting enzyme inhibitor benazeprilat in the treatment of hypertension and heart failure. It has a role as an EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor and a prodrug. It is an ethyl ester, a lactam, a benzazepine and a dicarboxylic acid monoester. It is functionally related to a benazeprilat. It is a conjugate base of a benazepril(1+).", "chebi": "A benzazepine that is benazeprilat in which the carboxy group of the 2-amino-4-phenylbutanoic acid moiety has been converted to the corresponding ethyl ester. It is used (generally as its hydrochloride salt) as a prodrug for the angiotensin-converting enzyme inhibitor benazeprilat in the treatment of hypertension and heart failure.", "chembl": "BENAZEPRIL is a small molecule listed in the ChEMBL database and has reached clinical trial phase 4.0.", "wikipedia": "Benazepril, sold under the brand name Lotensin among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease. It is a reasonable initial treatment for high blood pressure. It is taken by mouth. Versions are available as the combinations benazepril/hydrochlorothiazide and benazepril/amlodipine.\nCommon side effects include feeling tired, dizziness, cough, and light-headedness with standing. Serious side effects may include kidney problems, low blood pressure, high blood potassium, and angioedema. Use in pregnancy may harm the baby, while use when breastfeeding may be safe. It is an ACE inhibitor and works by decreasing renin-angiotensin-aldosterone system activity.\nBenazepril was patented in 1981 and came into medical use in 1990. It is available as a generic medication. In 2023, it was the 172nd most commonly prescribed medication in the United States, with more than 2 million prescriptions.\n\n"}